Jeremy A. Tigan
View All Practices
Jeremy is a partner in the Intellectual Property Litigation practice and serves on the firm’s Recruiting Committee. He represents clients as lead or Delaware counsel in litigation in the District of Delaware in a wide variety of industries, with a particular focus on pharmaceuticals, software, and networking technology.
He has served as lead counsel for Recro, Alkermes, Elan, Solenis, Netflix, Versata, and others in patent and trademark cases. In 2013, Jeremy completed the Federal Trial Practice Seminar, sponsored by the U.S. District Court for the District of Delaware and the Federal Bar Association. Prior to law school, Jeremy worked for the investigatory arm of the National Association of Securities Dealers.
He has been ranked by Chambers USA among leading Delaware practitioners in the Intellectual Property area, selected as a IAM Patent 1000 leading Delaware patent litigator, selected for inclusion in The Best Lawyers in America, and recognized as a Rising Star in Super Lawyers.
Experience
CyDex Pharmaceuticals, Inc. v. Lupin Limited et al, C.A. No. 19-02043 (D. Del.); CyDex Pharmaceuticals, Inc. v. Alembic Global Holding SA et al, C.A. No. 19-00956 (D. Del.); CyDex Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. et al, C.A. No. 17- 01832 (D. Del.)
Pharmacyclics LLC, et al. v. Cipla Ltd., et al., C.A. No. 18-192 (D. Del.)
Roche Diagnostics Corporation v. Meso Scale Diagnostics, LLC, C.A. No. 17-189 (D. Del.)
Liqwd, Inc. et al v. L'Oreal USA, Inc. et al., C.A. No. 17-14 (D. Del.)
Galderma Laboratories LP et al v. Teva Pharmaceuticals U.S.A., Inc., C.A. No. 17-1783 (D. Del.)
Integra LifeSciences Corp., et al. v. HyperBranch Medical Technology, Inc.,A. No. 15-819 (D. Del.)
Recro Gainesville LLC v. Actavis Laboratories FL, Inc., C.A. No. 14-1118 (D. Del.); Recro Gainesville LLC v. Alvogen Malta Operations Ltd., C.A. No. 14-1364 (D. Del.); Recro Gainesville LLC v. Actavis Laboratories FL, Inc., Fed. Cir., No. 17-1822
Superior Oil Co. v. Solenis Technologies L.P., C.A. No. 15-183-GMS (D. Del.); Buckman Laboratories, Inc. v. Solenis, LLC, C.A. No. 2:15-cv-2063-JPM-tmp (W.D. Tenn.); Hydrite Chemical Co. v. Solenis Technologies LP, C.A. No. 2:15-cv-00856 (E.D. Wisc.)
Cadence Pharms., Inc., SCR Pharmatop, & Mallinckrodt IP v. InnoPharma Licensing LLC & InnoPharma Inc., C.A. No. 14-1225 (D. Del.); Cadence Pharms, Inc., SCR Pharmatop, & Maillinckrodt IP v. Agila Specialties Inc. & Mylan Labs., Ltd., C.A. No. 14-1499 (D. Del.)
Butamax Advanced Biofuels LLC v. Gevo Inc., C.A. No. 11-054-SLR (D. Del.) (Phase I case)
News & Insights
Media Mention, Chambers USA, 05.20.2021The 2021 edition of Chambers USA has again ranked Morris Nichols in the top tier in four Delaware practice categories.
Professional & Civic
American Bar Association
American Intellectual Property Law Association
Delaware State Bar Association
Federal Bar Association Delaware Chapter (Intellectual Property Law Section, co-chair)
Federal Civil Panel
Law360 Intellectual Property Editorial Advisory Board
Education
George Mason University School of Law, JD, cum laude, 2007
Moot Court Board
National Moot Court Competition Team
2013 Federal Trial Practice Seminar, sponsored by the US District Court for the District of Delaware and the Federal Bar Association
The George Washington University, MA, political science, with distinction, 2004
University of Oregon, BS, political science, 2002
Admissions
- Delaware, 2008
- US District Court for the District of Delaware, 2009
- US Court of Appeals for the Third Circuit, 2013
- US Court of Appeals for the Federal Circuit, 2011